Hinova Pharmaceuticals Inc. (SHA:688302)
China flag China · Delayed Price · Currency is CNY
40.76
-0.20 (-0.49%)
Apr 29, 2026, 4:00 PM EDT

Hinova Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
436.79438.18633.44813.231,202901.22
Upgrade
Trading Asset Securities
390.95310.59210.49290.62366.24-
Upgrade
Cash & Short-Term Investments
827.74748.77843.931,1041,568901.22
Upgrade
Cash Growth
5.76%-11.28%-23.55%-29.59%73.97%-20.85%
Upgrade
Accounts Receivable
3.080----
Upgrade
Other Receivables
1.050.510.841.391.670.54
Upgrade
Receivables
4.130.520.841.391.670.54
Upgrade
Inventory
4.72.8500.010.010
Upgrade
Prepaid Expenses
-----13.09
Upgrade
Other Current Assets
44.25154.240.7741.9941.7840.38
Upgrade
Total Current Assets
880.83906.34885.541,1471,611955.24
Upgrade
Property, Plant & Equipment
357.66356.03328.62187.9986.6112.72
Upgrade
Long-Term Investments
13.813.8113.09109.985-
Upgrade
Other Intangible Assets
30.9531.0830.5631.2131.86-
Upgrade
Long-Term Deferred Charges
---0.040.08-
Upgrade
Other Long-Term Assets
2.642.513.7715.120.2114.39
Upgrade
Total Assets
1,2861,3101,3621,4921,735982.35
Upgrade
Accounts Payable
91.5288.5540.633.142.291.31
Upgrade
Accrued Expenses
4.868.4331.0949.1769.8190.45
Upgrade
Short-Term Debt
----30-
Upgrade
Current Portion of Long-Term Debt
2.933.3----
Upgrade
Current Portion of Leases
--3.223.772.452.8
Upgrade
Current Income Taxes Payable
1.381.58----
Upgrade
Current Unearned Revenue
4.163.8----
Upgrade
Other Current Liabilities
20.2420.2572.0150.7633.7396.77
Upgrade
Total Current Liabilities
125.08125.9146.95106.84138.27191.33
Upgrade
Long-Term Debt
100100----
Upgrade
Long-Term Leases
2.112.595.839.083.311.11
Upgrade
Long-Term Unearned Revenue
24.4717.4916.558.558.11.15
Upgrade
Other Long-Term Liabilities
0.470.2----
Upgrade
Total Liabilities
252.12246.19169.33124.47149.68193.59
Upgrade
Common Stock
99.0299.0299.0299.0299.0274.26
Upgrade
Additional Paid-In Capital
2,5922,5922,5832,5582,4821,409
Upgrade
Retained Earnings
-1,657-1,627-1,490-1,290-996.06-694.54
Upgrade
Comprehensive Income & Other
-0.22-0.15-0.030.110.14-0.07
Upgrade
Total Common Equity
1,0341,0641,1921,3671,585788.76
Upgrade
Shareholders' Equity
1,0341,0641,1921,3671,585788.76
Upgrade
Total Liabilities & Equity
1,2861,3101,3621,4921,735982.35
Upgrade
Total Debt
105.04105.899.0512.8535.763.91
Upgrade
Net Cash (Debt)
722.71642.88834.881,0911,532897.31
Upgrade
Net Cash Growth
-6.67%-23.00%-23.48%-28.79%70.74%-21.16%
Upgrade
Net Cash Per Share
7.336.518.4111.0216.8712.07
Upgrade
Filing Date Shares Outstanding
99.6199.0299.0299.0299.0274.26
Upgrade
Total Common Shares Outstanding
99.6199.0299.0299.0299.0274.26
Upgrade
Working Capital
755.75780.43738.591,0401,473763.91
Upgrade
Book Value Per Share
10.3810.7412.0413.8116.0110.62
Upgrade
Tangible Book Value
1,0031,0321,1621,3361,554788.76
Upgrade
Tangible Book Value Per Share
10.0710.4311.7313.4915.6910.62
Upgrade
Machinery
--17.1515.4914.8511.16
Upgrade
Construction In Progress
--314.5169.5473.763
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.